Helen and Arthur E. Johnson Depression Center, University of Colorado School of Medicine, Aurora, CO, USA.
VA Puget Sound Health Care System, Seattle, WA, USA.
Curr Psychiatry Rep. 2017 Sep 18;19(11):80. doi: 10.1007/s11920-017-0836-0.
This review provides an overview of the current evidence base for and clinical applications of the use of virtual reality (VR) in psychiatric practice, in context of recent technological developments.
The use of VR in psychiatric practice shows promise with much of the research demonstrating clinical effectiveness for conditions including post-traumatic stress disorder, anxiety and phobias, chronic pain, rehabilitation, and addictions. However, more research is needed before the use of VR is considered a clinical standard of practice in some areas. The recent release of first generation consumer VR products signals a change in the viability of further developing VR systems and applications. As applications increase so will the need for good quality research to best understand what makes VR effective, and when VR is not appropriate for clinical services. As the field progresses, it is hopeful that the flexibility afforded by this technology will yield superior outcomes and a better understanding of the underlying mechanisms impacting those outcomes.
本文综述了虚拟现实(VR)在精神科实践中的当前证据基础和临床应用,结合了最近的技术发展情况。
在精神科实践中使用 VR 具有很大的前景,大量研究表明 VR 对包括创伤后应激障碍、焦虑和恐惧症、慢性疼痛、康复和成瘾在内的多种疾病具有临床有效性。然而,在某些领域将 VR 的使用视为临床标准之前,还需要更多的研究。第一代消费类 VR 产品的推出标志着进一步开发 VR 系统和应用的可行性发生了变化。随着应用的增加,需要高质量的研究来更好地了解是什么使 VR 有效,以及何时 VR 不适合临床服务。随着该领域的发展,希望这项技术的灵活性将产生更好的结果,并更好地理解影响这些结果的潜在机制。